100 related articles for article (PubMed ID: 21875379)
21. Effect of anti-muscarinic autoantibodies on leukocyte function in Sjögren's syndrome.
Namkoong E; Lee SW; Kim N; Choi Y; Park K
Mol Immunol; 2017 Oct; 90():136-142. PubMed ID: 28750255
[TBL] [Abstract][Full Text] [Related]
22. Autoantibodies against cerebral muscarinic cholinoceptors in Sjögren syndrome: functional and pathological implications.
Reina S; Sterin-Borda L; Orman B; Borda E
J Neuroimmunol; 2004 May; 150(1-2):107-15. PubMed ID: 15081254
[TBL] [Abstract][Full Text] [Related]
23. Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjögren's syndrome.
Cavill D; Waterman SA; Gordon TP
Scand J Immunol; 2004 Mar; 59(3):261-6. PubMed ID: 15030576
[TBL] [Abstract][Full Text] [Related]
24. Autoantigen-specific memory B cells in primary Sjögren's syndrome.
Aqrawi LA; Skarstein K; Bredholt G; Brun JG; Brokstad KA
Scand J Immunol; 2012 Jan; 75(1):61-8. PubMed ID: 21916919
[TBL] [Abstract][Full Text] [Related]
25. T cell reactivity to Sjögren's syndrome related antigen La(SSB).
Helsloot J; Sturgess A
J Rheumatol; 1997 Dec; 24(12):2340-7. PubMed ID: 9415639
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune response and target autoantigens in Sjogren's syndrome.
Routsias JG; Tzioufas AG
Eur J Clin Invest; 2010 Nov; 40(11):1026-36. PubMed ID: 20629708
[TBL] [Abstract][Full Text] [Related]
27. [Anti-M3 muscarinic acetylcholine receptor antibodies and Sjögren's syndrome].
Tsuboi H; Iizuka M; Asashima H; Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(2):77-85. PubMed ID: 23629427
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effects of autoantibodies on the muscarinic receptors in Sjögren's syndrome.
Li J; Ha YM; Kü NY; Choi SY; Lee SJ; Oh SB; Kim JS; Lee JH; Lee EB; Song YW; Park K
Lab Invest; 2004 Nov; 84(11):1430-8. PubMed ID: 15448705
[TBL] [Abstract][Full Text] [Related]
29. Autoantibodies in primary Sjögren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis.
Gordon TP; Bolstad AI; Rischmueller M; Jonsson R; Waterman SA
Autoimmunity; 2001; 34(2):123-32. PubMed ID: 11905842
[TBL] [Abstract][Full Text] [Related]
30. M3 muscarinic acetylcholine receptor-reactive Th17 cells in primary Sjögren's syndrome.
Abe S; Tsuboi H; Kudo H; Asashima H; Ono Y; Honda F; Takahashi H; Yagishita M; Hagiwara S; Kondo Y; Matsumoto I; Sumida T
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32614803
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome].
Tsuboi H; Matsuo N; Iizuka M; Nakamura Y; Matsumoto I; Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(4):222-8. PubMed ID: 20818151
[TBL] [Abstract][Full Text] [Related]
32. [Molecular mechanism on Sjögren's syndrome].
Sumida T; Matsumoto I; Namekawa T; Kita Y
Nihon Rinsho; 1995 Oct; 53(10):2395-400. PubMed ID: 8531344
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren's syndrome.
Nakamura H; Kawakami A; Eguchi K
Transl Res; 2006 Dec; 148(6):281-8. PubMed ID: 17162248
[TBL] [Abstract][Full Text] [Related]
34. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands.
Wang Y; Virji AS; Howard P; Sayani Y; Zhang J; Achu P; McArthur C
Arch Oral Biol; 2006 Jul; 51(7):558-66. PubMed ID: 16405863
[TBL] [Abstract][Full Text] [Related]
35. Siögren's syndrome: anti-Ro and anti-La autoantibodies trigger apoptotic mechanism in the human salivary gland cell line, A-253.
Lisi S; Sisto M; Scagliusi P; Mitolo V; D'Amore M
Panminerva Med; 2007 Sep; 49(3):103-8. PubMed ID: 17912146
[TBL] [Abstract][Full Text] [Related]
36. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
Kobayashi M; Yasui N; Ishimaru N; Arakaki R; Hayashi Y
Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
[TBL] [Abstract][Full Text] [Related]
37. Sjögren's syndrome: viewpoint on pathogenesis. One of the reasons I was never asked to write a textbook chapter on it.
Konttinen YT; Käsnä-Ronkainen L
Scand J Rheumatol Suppl; 2002; 116():15-22. PubMed ID: 12109538
[TBL] [Abstract][Full Text] [Related]
38. A novel cell-based assay for inhibitory anti-muscarinic type 3 receptor antibodies in primary Sjögren's syndrome.
Bastian I; Gordon TP; Jackson MW
J Immunol Methods; 2015 Dec; 427():117-21. PubMed ID: 26584897
[TBL] [Abstract][Full Text] [Related]
39. Autoantigens and Sjögren syndrome.
Toda I
Cornea; 2002 Mar; 21(2 Suppl 1):S13-6. PubMed ID: 11995803
[TBL] [Abstract][Full Text] [Related]
40. Anti-M(3) peptide IgG from Sjögren's syndrome triggers apoptosis in A253 cells.
Reina S; Sterin-Borda L; Borda E
Cell Immunol; 2012; 275(1-2):33-41. PubMed ID: 22513175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
